Clin2
NCT06710015Possibly a fitNot yet recruiting

Fertility in women with BRCA gene changes

BRCA1 and/or BRCA2 Variant CarriersFertilityReproductive AgeMenopausePregnancy Outcomes

Part of Genetic & congenital, Women’s health & pregnancy clinical trials.

This study looks at how BRCA gene changes (mutations) may affect fertility in women. By comparing women with BRCA mutations to their relatives without the mutation, researchers hope to learn more about fertility and family planning for those affected.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
128 people
Ages
18 years to 100 years
Study type
Observational

Who can take part

  • You are 18 years old or older.
  • You have a confirmed BRCA1 or BRCA2 gene mutation (or are a close relative without the mutation).
  • You are willing to sign a consent form to join the study.
  • You do not have a mutation in another cancer-risk gene besides BRCA.
  • You are able to understand the study and give your consent.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03296826Recruiting
Study for women with BRCA gene changes

This study follows women who carry BRCA1 or BRCA2 gene variants (or a gene variant of unclear meaning) to learn about their risks over time. It may help improve how genetic information is used to guide future care.

Okayama
NCT07376681Enrolling by invitation
Fertility in young breast cancer patients

This study looks at fertility, cancer outcomes, and children's health in women diagnosed with breast cancer at age 40 or younger. It aims to help you understand how breast cancer and its treatment may affect your ability to have children and your long-term health.

Taizhou, Zhejiang
NCT05835739Recruiting
Study of breast cancer prevention in BRCA1/2 mutation carriers

This is an observational study that looks at how different cancer prevention approaches affect women with harmful (deleterious) BRCA1 or BRCA2 mutations. It may help improve future prevention and follow-up plans for women at higher inherited risk.

Aviano, Pordenone
NCT07617025Recruiting
Understanding Breast Cancer Subtypes in BRCA Carriers

This study examines how different molecular subtypes (patterns of genes and proteins) of breast cancer behave in people with BRCA1 or BRCA2 mutations. By studying tumor samples and medical records, researchers hope to better predict which treatments will work best and predict long-term outcomes for BRCA-positive breast cancer patients.

Genova
NCT07821593Recruiting
Experiences after preventive mastectomy for BRCA gene carriers

This study asks women who carry a BRCA1 or BRCA2 gene change and chose to have their breasts removed to prevent cancer about their experiences after surgery. Participation involves filling out a survey about your feelings and recovery.

Pavia, Pavia
NCT06775470Recruiting
How BRCA gene variants affect ovarian cancer treatment results

This study looks at how different BRCA gene changes affect how well ovarian cancer responds to treatment and the long-term outlook. If you were diagnosed with ovarian cancer and had BRCA testing at Bologna's S.Orsola hospital, your data could help researchers better understand treatment outcomes.

Bologna

Hear when a new Fertility trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.